{"doi":"10.1089/aid.2009.0132","title":"HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry","abstract":null,"journal":"AIDS Research and Human Retroviruses","year":2010,"id":19450,"datarank":2.3662529998531374,"base_score":4.02535169073515,"endowment":4.02535169073515,"self_citation_contribution":0.6038027536102726,"citation_network_contribution":1.7624502462428646,"self_endowment_contribution":0.6038027536102726,"citer_contribution":1.7624502462428646,"corpus_percentile":null,"corpus_rank":null,"citation_count":55,"citer_count":47,"citers_with_citation_signal":41,"citers_with_endowment":41,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":131790,"name":"Heather Amrine-Madsen","orcid":null,"position":1,"is_corresponding":false},{"id":131791,"name":"John L. Miamidian","orcid":null,"position":2,"is_corresponding":false},{"id":131792,"name":"Kathryn M. Kitrinos","orcid":null,"position":3,"is_corresponding":false},{"id":131793,"name":"Jennifer Pfaff","orcid":null,"position":4,"is_corresponding":false},{"id":131794,"name":"James F. Demarest","orcid":null,"position":5,"is_corresponding":false},{"id":131795,"name":"Neelanjana Ray","orcid":null,"position":6,"is_corresponding":false},{"id":131796,"name":"Jerry L. Jeffrey","orcid":null,"position":7,"is_corresponding":false},{"id":131797,"name":"Celia C. Labranche","orcid":null,"position":8,"is_corresponding":false},{"id":131313,"name":"Robert W. Doms","orcid":null,"position":9,"is_corresponding":false},{"id":131311,"name":"John C. Tilton","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.02535169073515,"endowment":4.02535169073515,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20055594","pmcid":"PMC2858898","openalex_id":"https://openalex.org/W2034799492","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"F32 1F32AI077370-01","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"R01 AI040880","title":null}],"total_grants":2,"fwci":4.2848,"citation_percentile":0.94954849,"influential_citations":5,"citation_trend":[{"year":2012,"count":7},{"year":2013,"count":11},{"year":2014,"count":4},{"year":2015,"count":5},{"year":2016,"count":1},{"year":2017,"count":4},{"year":2024,"count":1}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858898","host_type":"repository"},{"url":"https://europepmc.org/articles/pmc2858898?pdf=render","host_type":"GREEN"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858898","host_type":"repository"},{"url":"http://www.liebertpub.com/doi/pdf/10.1089/aid.2009.0132","host_type":"publisher"},{"url":"https://doi.org/10.1089/aid.2009.0132","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20055594","host_type":"repository"}],"fields_of_study":["HIV Research and Treatment","HIV/AIDS drug development and treatment","Immune Cell Function and Interaction","Medicine","Biology","Benzoates","Cell Line","Cells, Cultured","Diketopiperazines","Drug Resistance, Viral","HIV Fusion Inhibitors","HIV Infections","HIV-1","Humans","Microbial Sensitivity Tests","Mutation, Missense","Piperazines","Receptors, HIV","Sequence Analysis, DNA","Spiro Compounds","Virus Internalization","env Gene Products, Human Immunodeficiency Virus"],"mesh_terms":["Benzoates","Cell Line","Cells, Cultured","Humans","Microbial Sensitivity Tests","Piperazines","Spiro Compounds","HIV-1","HIV Infections","Receptors, HIV","Sequence Analysis, DNA","Mutation, Missense","HIV Fusion Inhibitors","Drug Resistance, Viral","Virus Internalization","env Gene Products, Human Immunodeficiency Virus","Diketopiperazines"],"keywords":["CCR5 receptor antagonist","Maraviroc","Enfuvirtide","Virology","Biology","Drug resistance","Entry inhibitor","Viral entry","Virus","Viral replication","Receptor","Immunology","Gp41","Microbiology","Human immunodeficiency virus (HIV)","Genetics","Antibody","Chemokine receptor","Chemokine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"gen"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-04T04:09:13.347885Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}